First Commercial U.S. Case Performed at Cooper Last Week
Joseph V. Lombardi, MD, FACS, head, Division of Vascular and Endovascular Surgery and director of the Cooper Aortic Center at Cooper University Health Care, served as global principal investigator for a new device to treat aortic dissection, a potentially fatal medical condition if left untreated.
Cook Medical’s Zenith Dissection Endovascular System, approved for use by the FDA earlier this year, is a type of flexible stent graft specifically used to treat patients who have a tear (dissection) in the inside lining of the descending thoracic aorta, the large artery in the chest. Read more.